Photodynamic Therapy With Aminolevulinic Acid Topical Solution and Visible Blue Light in the Treatment of Multiple Actinic Keratoses of the Face and Scalp: Investigator-Blinded, Phase 3, Multicenter Trials

Archives of Dermatology

Volumn 140, Issue 1, 2004, Pages 41-46

  Piacquadio, Daniel J ^a,n   Chen, Diana M ^b,m   Farber, Harold F ^l   Fowler Jr , Joseph F ^h   Glazer, Scott D ^l   Goodman, J John ^j   Hruza, Luciann L ⁱ   Jeffes, Edward W B ^c   Ling, Mark R ^k   Phillips, Tania J ^d   Rallis, Tena M ^f   Scher, Richard K ^g   Taylor, Charles R ^e   Weinstein, Gerald David ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d BOSTON UNIVERSITY   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f UNIVERSITY OF UTAH   (United States)

^g Och Spine at New York Presbyterian Hospitals   (United States)

^h University of Louisville School of Medicine   (United States)

ⁱ WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j RADIANT RESEARCH   (United States)

^k MedaPhase Inc   (United States)

^l Therapeutics Inc ^*

^m ABBOTT LABORATORIES   (United States)

ⁿ Therapeutics Inc   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID;

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; BLUE LIGHT; BURNING SENSATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; EDEMA; ERYTHEMA; FACE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETREATMENT; SCALP; SKIN DEFECT; TREATMENT OUTCOME; TREATMENT PLANNING;

ADMINISTRATION, TOPICAL; ADULT; AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; FACIAL DERMATOSES; FEMALE; HUMANS; KERATOSIS; MALE; MIDDLE AGED; PHARMACEUTICAL SOLUTIONS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SCALP DERMATOSES; SINGLE-BLIND METHOD;

EID: 9144225389     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.140.1.41     Document Type: Article

References (19)

1. Schwartz RA, Stoll HL Jr. Epithelial precancerous lesions. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF, eds. Dermatology in General Medicine. New York, NY: McGraw Hill; 1995:804-821.
2. Marks R, Foley P, Goodman G, Hage BH, Selwood TS. Spontaneous remission of solar keratoses: the case for conservative management. Br J Dermatol. 1986;115:649-655.
3. Marks R, Rennie G, Selwood TS. Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet. 1988;1:795-797.
4. Guenthner S, Hurwitz R, Buckel L, Gray H. Cutaneous squamous cell carcinomas consistently show histologic evidence of in situ changes: a clinicopathologic correlation. J Am Acad Dermatol. 1999;41:443-448.
5. Yantsos VA, Conrad N, Zabawski E, Cockerell CJ. Incipient intraepidermal cutaneous squamous cell carcinoma: a proposal for reclassifying and grading solar (actinic) keratoses. Semin Cutan Med Surg. 1999;18:3-14.
6. American Academy of Dermatology. Guidelines of care for actinic keratoses. J Am Acad Dermatol. 1995;32:95-98.
7. Dougherty TJ, Marcus SL. Photodynamic therapy. Eur J Cancer. 1992;28A:1734-1742.
8. Kennedy JC, Pottier RH. Endogenous protoporphyrin, IX: a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B. 1992;14:275-292.
9. Jeffes EW, McCullough JL, Weinstein GD, et al. Photodynamic therapy of actinic keratosis with topical 5-aminolevulinic acid: a pilot dose-ranging study. Arch Dermatol. 1997;133:727-732.
10. Peng Q, Berg K, Moan J, Kongshaug M, Nesland JM. 5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research. Photochem Photobiol. 1997;65:235-251.
11. Jeffes EW, McCullough JL, Weinstein GD, Kaplan R, Glazer, SD, Taylor JR. Photodynamic therapy of actinic keratoses with topical aminolevulinic acid hydrochloride and fluorescent blue light. J Am Acad Dermatol. 2001;45:96-104.
12. Kennedy JC, Marcus SL, Pottier RH. Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): mechanisms and clinical results. J Clin Laser Med Surg. 1996;14:289-304.
13. Wolf P, Rieger E, Kerl H. Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid: an alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal cell carcinomas? J Am Acad Dermatol. 1993;28:17-21.
14. Calzavara-Pinton PG. Repetitive photodynamic therapy with topical delta aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours. J Photochem Photobiol B. 1995;29:53-57.
15. Karrer S, Baumler W, Abels C, Hohenleutner U, Landthaler M, Szeimies RM. Long pulse dye laser for photodynamic therapy: investigations in vitro and in vivo. Lasers Surg Med. 1999;25:51-59.
16. Szeimies RM, Karrer S, Radakovic-Fijan S, et al. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: a prospective, randomized study. J Am Acad Dermatol. 2002;47:258-262.
17. Goette DK. Topical chemotherapy with 5-fluorouracil. J Am Acad Dermatol. 1981;4:633-639.
18. Dillaha CJ, Jansen GT, Honeycutt WM, Bradford AC. Selective cytotoxic effect of topical 5-fluorouracil. Arch Dermatol. 1983;119:774-783.
19. ICN Pharmaceuticals Inc. Prescribing information for Efudex. 2000. Available at: http://www.efudex.com/efudexprescription.pdf. Accessed June 25, 2003.